These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 9452393)
1. Risk for transfusion-transmitted infectious diseases in Central and South America. Schmunis GA; Zicker F; Pinheiro F; Brandling-Bennett D Emerg Infect Dis; 1998; 4(1):5-11. PubMed ID: 9452393 [TBL] [Abstract][Full Text] [Related]
2. Prevention of transfusional Trypanosoma cruzi infection in Latin America. Schmunis GA Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():93-101. PubMed ID: 10677696 [TBL] [Abstract][Full Text] [Related]
3. [Risk of Chagas disease through transfusions in the Americans]. Schmuñis GA Medicina (B Aires); 1999; 59 Suppl 2():125-34. PubMed ID: 10668254 [TBL] [Abstract][Full Text] [Related]
4. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Schmunis GA; Zicker F; Cruz JR; Cuchi P Am J Trop Med Hyg; 2001 Dec; 65(6):924-30. PubMed ID: 11792000 [TBL] [Abstract][Full Text] [Related]
5. Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997. Schmuñis GA; Zicker F; Segura EL; del Pozo AE Transfusion; 2000 Sep; 40(9):1048-53. PubMed ID: 10988304 [TBL] [Abstract][Full Text] [Related]
6. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512 [TBL] [Abstract][Full Text] [Related]
7. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil. Maresch C; Schluter PJ; Wilson AD; Sleigh A Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323 [TBL] [Abstract][Full Text] [Related]
8. A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso. Kania D; Sangaré L; Sakandé J; Koanda A; Nébié YK; Zerbo O; Combasséré AW; Guissou IP; Rouet F Transfusion; 2009 Oct; 49(10):2237-40. PubMed ID: 19903285 [TBL] [Abstract][Full Text] [Related]
9. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
10. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018 [TBL] [Abstract][Full Text] [Related]
12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related]
13. Communicable diseases in the immigrant population attended to in a tropical medicine unit: epidemiological aspects and public health issues. Manzardo C; Treviño B; Gómez i Prat J; Cabezos J; Monguí E; Clavería I; Luis Del Val J; Zabaleta E; Zarzuela F; Navarro R Travel Med Infect Dis; 2008; 6(1-2):4-11. PubMed ID: 18342267 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development. García Z; Taylor L; Ruano A; Pavón L; Ayerdis E; Luftig RB; Visoná KA J Med Virol; 1996 Jul; 49(3):218-22. PubMed ID: 8818968 [TBL] [Abstract][Full Text] [Related]
15. [Towards the elimination of the transmission of Trypanosoma cruzi in Honduras and Central American countries]. Ponce C Medicina (B Aires); 1999; 59 Suppl 2():117-9. PubMed ID: 10668252 [TBL] [Abstract][Full Text] [Related]
16. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. van Hulst M; Hubben GA; Sagoe KW; Promwong C; Permpikul P; Fongsatitkul L; Glynn DM; Sibinga CT; Postma MJ Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093 [TBL] [Abstract][Full Text] [Related]
17. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood. Aggarwal V; Prakash C; Yadav S; Chattopadhya D Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388 [TBL] [Abstract][Full Text] [Related]
19. [Transfusion-induced virus infections: how great is the risk?]. Sibrowski W; Penner M; Kühnl P Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287 [TBL] [Abstract][Full Text] [Related]
20. Prevention of blood-borne diseases in Bolivia, 1993-2002. Schmunis GA; Rodriguez G; Coenen J; Bellorin EG; Gianella A Am J Trop Med Hyg; 2008 Nov; 79(5):803-8. PubMed ID: 18981527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]